> its part of the stack. earlier detection and improved treatments is a very important area. Earlier detection is important but mortality is a better metric th

> its part of the stack. earlier detection and improved treatments is a very important area. Earlier detection is important but mortality is a better metric than 5-year survival. People tend to conflate the two. If earlier detection doesn't decrease mortality then it's just goosing the 5-year numbers. This is especially true in geriatric cancers, particularly for example prostate cancers, where most of them are slow growing and not particularly dangerous. You'll outlive the cancer, so knowing about it doesn't mean, well, anything, other than exposing you to risky tests with serious side-effects. Prostate biopsy is really not great. No-treatment is a great choice in these cases, so really, the detection is all downside, no upside for asymptomatic cases. [1] [1] https://newsroom.ucla.edu/releases/older-prostate-cancer-patients-246132 https://newsroom.ucla.edu/releases/older-prostate-cancer-pat...